急性中耳炎に対するTebipenem pivoxilの有用性 : ―スコアリング・システムを用いた重症度評価とその臨床効果―
スポンサーリンク
概要
- 論文の詳細を見る
In recent years, high prevalence penicillin-resistant Streptococcus pnenumoniae (PRSP) strains and β-lactamase non-producing ampicillin-resistant Haemophilus influenzae (BLNAR) strains have been reported the treatment of acute otitis media (AOM) in children. Between September 2005 and March 2006, we performed a clinical efficacy study on Tebipenem-pivoxil (TBPM-PI) in children with acute otitis media. We assessed the severity of disease by using a scoring system based on symptoms and tympanic membrane changes, and a clinical efficacy study was carried out using the improvement in the score results cross linked in a table together with symptoms and TM findings and the objective grading of the physician in charge. 16 patients were enrolled in this study, ages were from 0 to 5 years old, with a median age of 3.50 years. S. pneumoniae, H. influenzae, and M. catarrhalis were detected as causative bacteria. The doses of TBPM-PI administered to children with AOM were 4 mg/kg b.i.d (10 cases) or 6 mg/kg b.i.d (6 cases) for seven days. The overall efficacy rates of TBPM-PI for AOM according to the clinical efficacy judged by the scoring system and the grading of attending physicians were 90.5% and 100%, respectively. The eradication rate of pathogens at the end of treatment was 4/4. Based on our results, the present study strongly suggested that TBPM-PI would be an effective antimicrobial agent against moderate to severe AOM. Moreover, the scoring system was very useful for the decision making regarding the appropriate treatment regimen of AOM.
論文 | ランダム
- 子宮体癌の化学療法と問題点 (特集 子宮体癌治療の最新トピックス)
- 198 胎児循環遺残症(PFC)に対するECMOの効果 : 適応疾患別の検討
- 脳室周囲白質軟化症の成因
- 古河スカイ(株)における温暖化対策 (特集 天然ガス化燃料転換の最前線)
- P-311 サイトメガロウイルス胎内感染症例に対するガンシクロビルの治療効果の検討